Abstract Sphingomyelin synthase (SMS) is a key enzyme involved in the generation of sphingomyelin (SM) and regulation of cell growth and survival. However, the effects of SMS on neuronal cell proliferation and cell cycle progression are not completely elucidated. In this study, we examined the direct effects of SMS1 in regulating cell cycle progression and proliferation of Neuro-2a cells that exhibit neuronal characteristics. Neuro-2a cells transfected with SMS-specific small hairpin RNA (shRNA) expressed significantly lower levels of SMS1. RNA interference-mediated depletion of SMS1 in Neuro-2a cells caused a significant decrease in SM levels. Decreased SMS1 levels resulted in reduced proliferation rate and morphological changes including neurite-like outgrowth. Also, silencing of SMS1 induced cell cycle arrest as shown by the increased percentage of cells in G0/G1 and decreased proportion of cells in S phase. These changes were accompanied by upregulation of cyclin-dependent kinase inhibitor p27 and decreased levels of cyclin D1 and phospho-Akt. Nuclear accumulation of p27 was also evident in SMS1-deficient cells. Furthermore, loss of SMS1 inhibited the migratory potential of Neuro-2a cells in association with decreased levels of matrix metalloproteinases. These results indicate that SMS1 plays an important role in mediating the key signaling pathways that are involved in the tight coordination of multiple cellular activities, including neuronal cell proliferation, cell cycle progression, and migration, and therefore may have significant implications in neurodegenerative diseases.
Introduction
The synthesis and metabolism of lipids are critical not only in cell membrane function but also in the regulation of cell proliferation and differentiation with implications in health and diseases [1] [2] [3] [4] [5] [6] [7] . Sphingomyelin synthase (SMS) is an important enzyme that controls growth and survival through the biosynthesis of sphingomyelin (SM) and diacylglycerol (DAG) from ceramide [8] [9] [10] [11] [12] . Many studies have linked SMS activity to enhanced cell proliferation and the suppression of apoptosis [11] [12] [13] [14] [15] [16] [17] [18] . However, overexpression of SMS1 is shown to increase the rate of apoptosis and inhibition of growth [19, 20] . Sphingolipids including SM are important regulators of various cellular processes including proliferation, migration, apoptosis, differentiation, angiogenesis, and inflammatory responses that are associated with various diseases [3, [6] [7] [8] [9] [10] [11] [12] . Particularly, a number of reports implicate the contribution of lipid metabolism and cell cycle-regulating proteins in cerebro-cardiovascular diseases including ischemic stroke [3, 6, 21] . A tumor cytotoxic agent tricyclodecan-9-yl-xanthogenate (D609) is reported to inhibit SMS activity [21] [22] [23] [24] . We have reported that D609 inhibits proliferation and cell cycle progression of microglia BV2 cells possibly through SMS inhibition [25] . Furthermore, bFGF-stimulated astrocyte proliferation is associated with SMS activity [15] . Despite these reports, the direct effects of SMS on cell cycle progression and proliferation of neuronal cells are not elucidated.
Cell proliferation and differentiation are tightly controlled by cyclin-dependent kinases (Cdks) whose activities are modulated by interactions with cyclins and Cdk inhibitors p27 and p21 [26] [27] [28] [29] . Independent of its Cdk inhibitory function, P27 is also shown to regulate the fundamental cellular processes, including cell differentiation and migration [28] [29] [30] [31] [32] [33] . Indeed, p27 inhibits cancer cell migration by binding to microtubuledestabilizing protein [34, 35] . Particularly, it is increasingly clear that p27 participates in the regulation of neuronal cell cycle, migration, and differentiation as shown in neuronal and neuroblastoma cells [36] [37] [38] [39] . Many of the above-mentioned functions including cellular proliferation and survival are regulated by the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway. Most notably, activation of Akt signaling promotes DNA synthesis and cell cycle progression in a variety of cell types including neuroblastoma cells [40] [41] [42] [43] . Indeed, RNA interference-mediated depletion of PI3K induces cell cycle arrest [43] . Interestingly, Akt signaling inhibits p27 transcription or accelerates p27 degradation in different cell types. Akt activation is also linked to impaired nuclear import of p27, and Akt inhibition restores nuclear p27 expression [44] [45] [46] . Recently, it has been shown that cytoplasmic retention of p27 promotes cell migration [46] [47] [48] . Tight regulation of neuronal cell migration is critical for proper establishment of neuronal functional networks, and thus, disruption of neuronal migration can lead to neurological disorders [38] . It is well established that the process of cell migration is regulated by metalloproteinases (MMPs) including MMP2 and MMP9 that act intrinsically as important signaling molecules, and their dysregulated expression can lead to pathological conditions [49] [50] [51] . Taken together, these studies have greatly increased our understanding of cellular functions, but the role of lipid-synthesizing enzymes in regulating these processes has received relatively little appreciation. Specifically, the role of SMS1 in regulating these signaling pathways and functions in cells of neuronal origin is not completely elucidated.
In this study, we examined the direct effects of SMS1 on cell proliferation, cell cycle progression, and migration of Neuro-2a, the cells of neuronal origin derived from the mouse brain. Here, we have demonstrated that inhibition of SMS1 expression by RNA interference significantly reduces the SM levels in association with cell cycle arrest, inhibited cell proliferation, and migratory potential of Neuro-2a cells. At the molecular level, SMS1 deficiency results in increased levels of p27 and decreased levels of cyclin D1, phospho-Akt, and MMP, the regulators of important signaling pathways.
Materials and Methods
Cell Culture and Establishment of Neuro-2a Cells Expressing SMS1-shRNA Neuro-2a, a mouse neuroblastoma cell line used in this study, was obtained from American Type Culture Collection (ATCC, Manassas, VA). These cells are derived from the brain and show neuronal-like characteristics. Cells were maintained in Dulbecco's modified Eagle's medium (DMEM, GIBCO-BRL) containing 10 % fetal calf serum (FCS) and 1 % penicillin and streptomycin (Life Technologies, Gaithersburg, MD) and were grown in a 5 % CO 2 incubator at 37°C. To silence the expression of SMS1 in Neuro-2a cells, we used small hairpin RNA (shRNA) plasmid containing 29-mer shRNA sequence in GFP vector targeted against the mouse SMS1 gene expression. Noneffective 29-mer-scrambled shRNA cassette in pGFP-V-RS Vector (Origene, Rockville, MD) was used as a control. GFP was used to monitor the efficiency of transfection. Cells were transfected with either control or SMS1-shRNA plasmid using lipofectamine 2000 (Life Technologies, Gaithersburg, MD). After selection with puromycin (1 μg/ml), cells were used for further studies.
Total RNA Isolation and Semiquantitative RT-PCR Total RNA was extracted using the RNAeasy extraction kit according to the manufacturer's protocol (Qiagen, Inc., Valencia, CA). The complementary DNAs (cDNAs) synthesized from total RNA (2 μg) using M-MLV reverse transcriptase and Oligo (dT) primer (Invitrogen) were used as templates for the reverse transcription (RT)-PCR reaction. The primer set used for SMS1 amplification was 5′-AACGGCATGATCCT TGTAGG-3′ and 5′-ATAAGCCACCTCCAGCAATG-3′, MMP2 amplification was 5′-GCTCCACCACATACAACT TTGA and 5′-TCGGGACAGAATCCATACTTCT, actin amplification using the primer set 5′-TGTTACCAACTGGGAC GACA-3′ and 5′-GGGGTGTTGAAGGTCTCAAA-3′ was used as the control. PCR amplifications were carried out in 30 cycles of denaturation (94°C, 1 min), annealing (58°C, 30 s), and extension (72°C, 1 min), and the products were analyzed on 1 % agarose gels.
Measurement of SM Levels Cell pellets were resuspended in 0.4 ml saline, and aliquots were taken for protein measurements. Total lipids were then extracted from the cell lysates into chloroform/methanol (1:2 by volume) containing 0.01 % butylated hydroxytoluene (BHT). After concentrating under a stream of nitrogen, total lipid extracts were applied to Whatman Partisil LK-5 silica gel thin-layer chromatography (TLC) plates with preconcentration zone (Fisher Scientific, Pittsburg, PA). SM was separated by development of the TLC in chloroform/ethanol/water/triethylamine (30:35:7:35) and identified using an authentic standard (Sigma, St. Louis, MO). The SM bands were scraped into 1.5 ml of methanol containing 0.01 % BHT, 30 μl of sulfuric acid, and 10 nmol of heptadecanoic acid as an internal standard. A corresponding blank region of the TLC was collected to correct for any background. SM was converted to fatty acid methyl esters by heating at 100°C for 2 h. The methyl esters were extracted into hexane and quantitated on a Hewlett Packard 6890 gas chromatograph (GC) equipped with a capillary column (HP cross-linked FFAP) and an autosampler.
Cell Proliferation Assay Cell proliferation was evaluated by a colorimetric assay that measures mitochondrial reductase catalyzed reduction of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT). The number of actively proliferating viable cells was determined by using MTT assay kit (Biotium, Hayward, CA) according to the manufacturer's protocol. Briefly, 5×10 3 cells per well were plated in triplicate on 96-well plates and cultured for 18 h in a 37°C incubator with 5 % CO 2 . The absorbance of released purple formazan that indicates cell viability was measured at 570 nm in a microtiter plate reader (Spectramax Plus 384, Molecular Devices, Sunnyvale, CA). Optical density values were determined, and the results were presented as mean values±SD of triplicates.
Cell Cycle Analysis The cell cycle parameters for Neuro-2a cells expressing either control or SMS1-shRNA were determined by flow cytometry of propidium iodide-stained cells. Briefly, from each group, 2×10 6 cells were washed in PBS containing 5 mM EDTA and fixed in 70 % ethanol at 4°C overnight. Cells were then resuspended in PBS containing 2 % FBS and 5 mM EDTA and were stained with 50 μg/ml propidium iodide and 1 mg/ml RNase A in PBS for 2 h at room temperature. Cells were then analyzed by flow cytometry (FACSCalibur, BD Biosciences, Fullerton, CA) to determine the cell cycle distribution. The percentage of cells present in G0/G1, S, and G2/M phases was determined using the ModFit software package (Verity Software House, Topsham, ME).
Scratch-Induced Cell Migration Assay and Trans well Cell
Invasion Assay Cell migration was analyzed as previously described [52] . In vitro injury was induced in SMS1-shRNA-transfected and control-shRNA-transfected cell monolayers by creating one to two linear scratches of ±0.2 mm wide, after which detached cells were removed and fresh medium was added. Cells were photographed at 2 and 24 h after wounding using a phase-contrast microscope interfaced with a digital camera. Trans well invasion assay was used for the quantitative measurement of Neuro-2a cell migration. In this assay, Neuro-2a cells transfected with either control or SMS1-shRNA plasmids ( 1×10 5 ) were placed in the upper side of Boyden chambers containing Matrigel-coated Bio coat cell culture inserts (BD Biosciences, Bedford, MA) with 8-μm pores. The lower chamber was filled with 500 μl of serum containing culture medium. Cells were incubated for 24 h at 37°C, after which nonmigrated cells on the upper surface were removed from the membranes. The migrated cells attached to the lower surface were stained with cresyl violet and extracted in 200 μl of 0.2-M sodium acetate buffer.
Optical density values at 540 nm correlating with cell migration were plotted. Results are presented as mean values±SD of triplicates.
Western Blot Analysis Total protein was extracted from SMS1-shRNA-and control-shRNA-transfected cells using RIPA buffer (Boston Bioproducts, Ashland MA) containing protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO). Twenty micrograms of total protein was separated by SDS-PAGE and probed with respective antibodies, 1:1000 for phospho/total Akt, p27, and cyclin D1 (Cell Signaling, Danvers, MA); 1:500 for actin (Sigma Aldrich, St. Louis, MO), followed by incubation with secondary antibody conjugated to horseradish peroxidase at room temperature for 1 h. Signals were developed with chemiluminescence using an ECL kit (Thermofisher). Total Akt and actin were used as loading controls. The NIH ImageJ software program was used to quantitate the expression levels. The experiment was repeated twice, and the data are presented as mean values±SD.
Immunofluorescence Cells grown on coverslips were fixed with 3.7 % paraformaldehyde for 15 min at room temperature. Cells were then blocked and permealized by incubating in PBS containing 2 % milk and 0.1 % Triton X-100 for 1 h. Cells were incubated with the primary antibody for 1 h at 37°C. After cells were washed three times with PBS, they were incubated with Alexa Fluor-conjugated secondary antibody for 1 h at 37°C. Subsequently, cells were washed three times with PBS, stained with nuclear stain DAPI for 5 min, washed three times with PBS, and mounted on a microscope slide with Fluoromount (Diagnostic BioSystems, Pleasanton, CA). Specimens were observed and images were acquired using a Keyence, BZ-9000 fluorescence microscope (IL, USA).
Motility Pathway Focused Gene Expression Profiling by
Quantitative Real-Time PCR A PCR mouse cell motility array (SA Biosciences, Frederick, MD) that profiles the expression of 84 genes that regulate cell motility was used according to the manufacturer's protocol. Briefly, the cDNA generated from 2 μg of total RNA was combined with SYBR green qPCR master mix. Equal aliquots of this mixture were added to each well of the PCR array plates containing pre-dispensed gene-specific primer sets. qRT-PCR analysis was performed in an Applied Biosystems Prism 7000 Sequence Detection system and analyzed using GeneAmp 5700 SDS software. Relative quantification was performed using standard curves generated for each gene-specific primer pair. The values obtained from each set of gene-specific primers were normalized to endogenous control genes and used to determine relative expression levels. Levels of MMP2 messenger RNA (mRNA) were further validated using PCR assay.
Statistical Analysis A two-tailed, nonpaired Student's t test was used to predict statistical significance of the comparison between two means. The data is presented as means±SD. Results were considered significant at P≤.05 at 95 % confidence level.
Results

Establishment of Neuro-2a Cells Deficient in SMS1 Expression
To define the functional role of SMS1 in neuronal cells, we established Neuro-2a cells that express SMS1-specific small interfering RNA using SMS-shRNA-GFP plasmids. Using polymerase chain reaction, we confirmed that SMS1 mRNA levels were significantly decreased in SMS1-shRNA-transfected Neuro-2a cells. However, there was no alteration in SMS1 mRNA levels in Neuro-2a cells transfected with control plasmid encoding for scrambled control-shRNA. We used beta-actin as an internal control, which remained the same in both cell lines (Fig. 1a) . Quantification of images using NIH ImageJ software demonstrated more than 70 % decrease in SMS1 mRNA levels in SMS1-shRNA-transfected Neuro-2a as compared to control cells (Fig. 1b) . Immunofluorescence staining further confirmed the decrease in SMS1 protein in SMS1-shRNA-transfected Neuro-2a as compared to control cells (Fig. 1c) . We then examined if decreased SMS1 expression resulted in the decreased levels of SM, an important by-product of SMS1 activity. In SMS1-shRNAtransfected cells, SM levels were significantly decreased (about 30 %) as compared to cells transfected with controlshRNA plasmid (Fig. 1d) . (Fig. 2a) . Furthermore, SMS1 silencing in Neuro-2a cells induced about 30 % growth arrest as shown by MTT proliferation assay (Fig. 2b) . (Fig. 3a) . SMS1-shRNAtransfected Neuro-2a cells demonstrated cell cycle arrest with 77 % of cells in G1 phase, while about 55 % percent of the control-shRNA-transfected cells were in G1 phase. The percentage of cells in G2 phase decreased from about 18 % (control) to 11 % in SMS1-shRNA-transfected cells. The percentage of cells in S phase decreased by about 15 % in SMS1-deficient cells as compared to control-shRNAtransfected cells (Fig. 3b) . These results suggest that SMS1 silencing may block cell cycle progression of Neuro-2a cells by arresting them at G1 phase of the cell cycle.
Silencing of SMS1 Exerts
Morphological Changes and Antiproliferative Effect We monitored the effects of SMS1 silencing on growth and morphological features of Neuro-2a cells. Neuro-2a cells transfected with scrambled control-shRNA exhibited an amoeboid-like structure and grew in clusters with round morphology with short cytoplasmic processes. On the other hand, SMS1-shRNA-transfected cells exhibited smaller cell bodies with longer and branched axon-like processes resembling neuronal-like cells
SMS1 Silencing in Neuro-2a Cells Alters the Expression of Key Cell Cycle Regulating Proteins p27 and Cyclin D1
To gain further insight into the consequences of SMS1 loss on key cell cycle regulators, Neuro-2a cell lysates were subjected to Western blot analysis using p27, cyclin D1, and phosphoand total Akt antibodies. Cdk inhibitor p27 is an important regulator of the G1 cell cycle phase. The levels of p27 protein were significantly increased by SMS1 silencing. In contrast, cyclin D1 levels were significantly decreased in Neuro-2a cells after SMS1 silencing as compared to control cells (Fig. 4a) . Quantification and normalization of p27 and cyclin D1 protein levels relative to beta-actin demonstrated a 2-3-fold increase in p27 and a 2-3-fold decrease in cyclin D1 in SMS1-shRNA-transfected cells vs. cells transfected with control-shRNA (Fig. 4b) . Furthermore, we observed that silencing of SMS1 led to alterations in cellular localization of p27 protein. Decreased SMS1 resulted in a remarkable increase in nuclear p27 as seen by immunofluorescence staining (Fig. 4c ). These results demonstrate that Neuro-2a cell cycle arrest is induced by SMS1 knockdown and that p27 is involved in this process. The PI3-Akt pathway regulates p27 and plays a key role in cell proliferation, cell cycle, and survival in many cells. Hence, we examined whether SMS1 silencing inhibited the activation of Akt in Neuro-2a cells. As shown in Fig. 4d , the expression of phospho-Akt decreased significantly in SMS1-shRNA-transfected cells. Total Akt protein expression was unaffected. Quantification and normalization of phospho-Akt protein levels relative to total Akt demonstrated about a 3-fold decrease in phospho-Akt in SMS1-shRNA-transfected cells vs. cells transfected with control-shRNA. These results indicate that SMS1 knockdownmediated functions are associated with the regulation of key cell cycle and survival proteins.
SMS1 Silencing Inhibits the Migratory Potential of Neuro-2a
Cells Migratory potential is an integral part of many physiological processes and is regulated by p27 and Akt. Thus, we next examined the role of SMS1 in migratory properties of Neuro-2a cells using the scratch assay and the Boyden chamber assay that measure the migration of cells through a Matrigel-coated membrane. In the scratch assay, control Neuro-2a cells migrated to fill the scratched area after 24 h, indicating their strong migratory potential. However, silencing of SMS1 greatly reduced this migratory potential as indicated by an unfilled scratched area after 24 h (Fig. 5a) . Furthermore, the ability of SMS1-silenced Neuro-2a cells to invade through Matrigel-coated filters was significantly reduced (30 %) when compared with control cells (Fig. 5b) . These results demonstrate that SMS1 expression is an important regulator of neuronal cell migration.
SMS1 Is Associated with the Expression of Motility Genes
Including Matrix MMP in Neuro-2a Cells Motility regulating genes play critical roles in cell migration, cell cycle progression, and inflammatory responses. To examine whether the effects of SMS1 silencing on Neuro-2a cells are mediated through the regulation of these gene expression, we screened a mouse cell motility pathway-specific PCR array (Fig. 6a) . RNAs from control-shRNA-transfected Neuro-2a and SMS1-shRNA-transfected cells were analyzed in parallel. Interestingly, SMS1 silencing resulted in a greater than 3-fold downregulation of 23 genes. Particularly, MMP2 and MMP14 showed 57.8-and 6.5-fold decreases, respectively (Fig. 6b) . MMP9 levels were also decreased by 1.9-fold. In contrast, nine genes that showed upregulation were changed by only 1.5-to 3-fold (data not shown). Since MMP2 showed significantly decreased levels and its established role in cell migration and survival, its mRNA and protein levels were further validated. RT-PCR analysis confirmed the significant decrease in MMP2 mRNA levels in SMS1-silenced cells (Fig. 6c, d) , and immunofluorescence staining confirmed markedly decreased levels of MMP2 protein in SMS1-silenced Neuro-2a cells (Fig. 6e) . These results suggest that SMS1 expression in Neuro-2a cells may be involved in growth regulation at least in part through MMP signaling.
Discussion
In this study, we have demonstrated that small interfering RNA-mediated decrease in SMS1 expression leads to decreased SM levels in association with inhibited cell proliferation and cell cycle arrest of Neuro-2a cells. Furthermore, SMS1 deficiency decreases the migratory potential of these cells. At the molecular level, we have shown that effects of SMS1 silencing are mediated through alterations in the levels of p27, PI3K/Akt, and MMP2, the key signaling molecules that govern cell cycle progression and migration. These findings reinforce the importance of lipid synthesizing enzymes not only in cell membrane formation but also in regulation of Much progress has been made in sphingolipid biology. However, large gaps still remain in our knowledge of the cellular and molecular mechanisms controlled by the enzymes that regulate sphingolipids. SMS1 is the key enzyme responsible for bulk production of SM from ceramide, the key lipid molecule [8] [9] [10] [11] [12] . Although the concept of ceramide as a signaling and regulatory factor is well accepted, the specific role of SMS1 is only now emerging. Indeed, growing evidence supports a role for SM, a by-product of SMS, in modulating the signal transduction and fundamental biological functions, including cell growth and viability [1-20, 53, 54] . Given these crucial roles, understanding the role of the enzymes that regulate the balance of SM is of importance. Our previous work has shown that exposure of microglia to D609 that blocks the SMS activity inhibits cell proliferation by inducing cell cycle arrest. D609 also inhibited the proliferation of neural progenitor cells [25, 55] . Furthermore, SMS blocker D609 conferred neuro-protection in a rat model of ischemia [21] . However, the direct involvement of SMS1 in neuronal cell growth and cell cycle regulation remains speculative. Hence, we investigated further the specific role of SMS1 in neuronal cells. We used the Neuro-2a cell line that is of neuronal origin and has been extensively used as a cell culture model to study neuronal differentiation, axonal growth, and signaling pathways [36, 37, 56, 57] .
Our current finding that SMS1 deficiency inhibits cellular proliferation is consistent with other studies reporting involvement of SMS1 in enhancing cell proliferation and suppressing apoptosis [13] [14] [15] [16] [17] [18] 58] . On the other hand, overexpression and activation of SMS1 by 2-hydroxyoleic acid are shown to increase the rate of apoptosis and inhibition of cellular growth [19, 20] . The possible explanation for these differential effects of SMS and SM is that many of these studies were conducted using various cell types. Continued work in each cell type should increase our clear understanding of the role of SMS in key physiological functions. Furthermore, SMS1 silencing resulted in morphological changes in Neuro-2a cells. Since shapes of cells are associated with cell cycle distribution and migratory properties, SMS1 may be involved in regulating these functions. Collectively, these data strongly agree that maintaining balanced levels of SMS is critical for normal cellular functions, including cell cycle regulation. Indeed, in SMS-deficient Neuro-2a cells, we showed upregulation of a key cell cycle molecule, p27 concomitant with a decrease in cyclin D1 protein. Interestingly, p27 was predominantly expressed in the nuclei of the SMS-shRNA-transfected cells. Interestingly, previous studies have shown that PI3K/Aktmediated phosphorylation of p27 retains it in the cytoplasm and reduces its nuclear import. Akt also contributes to cell cycle regulation by inhibiting p27 transcription or accelerating p27 degradation in different cell types [44] [45] [46] [47] [48] . In support of these observations, SMS1-deficient Neuro-2a cells showed decreased Akt activation in association with increased p27. Thus, our studies thus define a novel mechanism linking SMS1 and Akt activation with modulation of p27 expression and localization in Neuro-2a cells. Specifically, how SMS1 regulates Akt signaling remains to be elucidated. Presumably, SMS1 may mediate extracellular stimuli and growth factor signaling linked to Akt activation that promotes cell cycle progression. Of note, previous study has demonstrated a link between basic fibroblast growth factor stimulation and increased SMS1 activity [15] . In addition, SMS deficiency potentiates the cytokine receptor CXCR4 dimerization and signal transduction [59] , and platelet-derived growth factor, as well as pro-inflammatory cytokines such as TNF-α, has been shown to activate sphingosine kinase, which regulates cellular viability and inflammatory responses [4] [5] [6] [7] . These results raise the intriguing possibility that SMS1 plays a key role in regulating cytokine and growth factor-mediated signaling pathways. However, it is yet to be determined whether SMS1 regulates cytokine and growth factor signaling in neuronal cells.
Neuronal cell migration is a dynamic process that is central to proper distribution and establishment of the neural network, disruption of which can lead to neurological disorders. Although molecular control of neuronal migration is well understood, how cell cycle and migration are coordinated at the molecular level is not clear. In this study, we examined the role of SMS1 in Neuro-2a cells using two different approaches. In the scratch assay, we observed inhibited migration as indicated by larger gap in wound/gap closure in SMS1-shRNAtransfected cells. It is possible that cell proliferation rate and viability can also contribute to decreased gap closure. However, the Boyden chamber assay clearly demonstrated inhibited cell migration in association with SMS1 silencing. Our current studies have found that SMS1 deficiencymediated inhibition of the migratory potential of Neuro-2a cells is associated with decreased levels of phospho-Akt and increased levels of p27, particularly in the nucleus. Indeed, Akt activation is shown to modulate p27-mediated cell migration. Matrix organization facilitated by matrix MMPs is shown to contribute significantly to migratory processes. In support of this, our current study using motility gene PCR array screening showed downregulation of MMP family members MMP2, MMP9, and MMP14 in SMS1-deficient Neuro-2a cells, suggesting that MMPs potentially participate in SMS1-mediated cell migration. Indeed, accumulating evidence demonstrates that sphingomyelin, a major component of microvesicles that also secrete MMPs, confers cellular migratory properties [59] . It is interesting that SMS1 is reported to exert negative effects on the migratory potential of mouse embryonic fibroblast [60] . This discrepancy is probably attributable to the difference in cell culture models, wherein lipid metabolism and pathways are likely controlled differently. Thus, alterations in tightly regulated SMS1 expression and activity can lead to dysregulated signaling pathways that may have significant implications in health and disease. Indeed, the impact of sphingolipid-mediated signaling is increasingly being appreciated in the pathogenesis of cerebrovascular and other diseases [1] [2] [3] [4] [5] [6] [7] . Further studies are certainly warranted for identifying the involvement of SMS1 in neurodegenerative diseases. Overall, our current study may provide important insight for exploring further the role of SMS1 in regulating neuronal cell growth and survival under pathophysiological conditions.
